GÜVEN, D. C. Et Al. 2021. Higher Systemic Immune-Inflammation Index (SII) Levels Are Associated With Poorer Survival In Immunotherapy-Treated Melanoma Patients. Eurasian Journal of Medical Investigation , vol.5, no.3 , 409-413.

GÜVEN, D. C., AKTEPE, O. H., YILDIRIM, H. Ç., ÇELİK, İ., & KILIÇKAP, S., (2021). Higher Systemic Immune-Inflammation Index (SII) Levels Are Associated With Poorer Survival In Immunotherapy-Treated Melanoma Patients. Eurasian Journal of Medical Investigation , vol.5, no.3, 409-413.

GÜVEN, DENİZ Et Al. "Higher Systemic Immune-Inflammation Index (SII) Levels Are Associated With Poorer Survival In Immunotherapy-Treated Melanoma Patients," Eurasian Journal of Medical Investigation , vol.5, no.3, 409-413, 2021

GÜVEN, DENİZ C. Et Al. "Higher Systemic Immune-Inflammation Index (SII) Levels Are Associated With Poorer Survival In Immunotherapy-Treated Melanoma Patients." Eurasian Journal of Medical Investigation , vol.5, no.3, pp.409-413, 2021

GÜVEN, D. C. Et Al. (2021) . "Higher Systemic Immune-Inflammation Index (SII) Levels Are Associated With Poorer Survival In Immunotherapy-Treated Melanoma Patients." Eurasian Journal of Medical Investigation , vol.5, no.3, pp.409-413.

@article{article, author={DENİZ CAN GÜVEN Et Al. }, title={Higher Systemic Immune-Inflammation Index (SII) Levels Are Associated With Poorer Survival In Immunotherapy-Treated Melanoma Patients}, journal={Eurasian Journal of Medical Investigation}, year=2021, pages={409-413} }